Koji Yahara
Group Leader
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (21)
Year:
2026
Year:
2025
Year:
2025
The ftsI locus of gram-negative bacteria encodes penicillin-binding protein 3 (PBP3), a common target of β-lactam antibiotics. Recent genomic surveillance of carbapenem-resistant Pseudomonas aeruginosa revealed that 17% of strains possessed nonsynonymous substitution in ftsI . However, the contribution of ftsI nonsynonymous substitution alone to the antimicrobial susceptibility of P. aeruginosa has not been formally evaluated. Therefore, we assessed the effect of ftsI nonsynonymous substitutions alone on β-lactam susceptibility in recombinant P. aeruginosa strains. The nonsynonymous substitutions C265G (Leu89Val), C1379T (Met460Thr), T1412G (Val471Gly), C1510T (Arg504Cys), C1579A (Pro527Thr), C1579T (Pro527Ser), C1599A (Phe533Leu), and G1609C (Val537Leu) were introduced into ftsI in an antimicrobial-susceptible strain via homologous recombination. Then, their β-lactam susceptibilities were investigated using the broth microdilution method and growth parameter analysis for the growth curves. The introduction of the N-terminal Leu89Val mutation did not alter β-lactam susceptibility. By contrast, the introduction of penicillin-binding (PB) domain mutations (Met460Thr, Val471Gly, Arg504Cys, Pro527Thr, Pro527Ser, Phe533Leu, or Val537Leu) reduced the susceptibility to meropenem and doripenem by two- to eightfold in MIC. Arg504Cys, the most common mutation encountered clinically, reduced susceptibility to cefepime by fourfold. Growth parameter analysis revealed that, conversely, these PB domain mutations generally increase the susceptibility to cefiderocol and piperacillin. The cocrystal structures of PBP3 with β-lactams suggest that the positions of PB domain mutations can affect the mobility of previously proposed key residues, namely, Tyr409, Arg489, Tyr503, Tyr532, Phe533, and the KSGT motif, via intramolecular interactions. These data demonstrated that seven specific variants in ftsI are genetic signals of bacterial adaptation to carbapenems. IMPORTANCE Previous studies have reported the occurrence of ftsI mutations under various genetic backgrounds in Pseudomonas aeruginosa clinical isolates. However, the nature of ftsI mutations by themselves has not been thoroughly investigated under a common genetic background using recombinant strains. This study presents experimental data on the effect of ftsI point mutations alone on bacterial susceptibility to a wide range of antipseudomonal β-lactams. This study found that seven specific penicillin-binding domain mutations in FtsI/PBP3 reduced the efficacy of carbapenems but increased the efficacies of piperacillin and cefiderocol. This key finding will facilitate the development of therapeutic options for carbapenem-resistant P. aeruginosa -associated infections. Furthermore, this study contributes to the development of a reliable database collating resistance-associated point mutations, which would aid the interpretation of genomic data on P. aeruginosa clinical isolates.
Year:
2025
Many recent lines of evidence from the human microbiome and other fields indicate bacterial involvement in various types of cancer. Helicobacter pylori has been recognized as the major cause of stomach cancer (gastric cancer), but the mechanism by which it destabilizes the human genome to cause cancer remains unclear. Our recent studies have identified a unique family of toxic restriction enzymes that excise a base (A: adenine) from their recognition sequence (5′-GTAC). At the resulting abasic sites (5′-GT_C), its inherent endonuclease activity or that of a separate endonuclease may yield atypical strand breaks that resist repair by ligation. Here, we present evidence demonstrating involvement of its H. pylori member, HpPabI, in stomach carcinogenesis: (i) Association of intact HpPabI gene with gastric cancer in the global H. pylori Genome Project and the open genomes; (ii) Frequent mutations at A in 5′-GTAC in the gastric cancer genomes as well as in H. pylori genomes; (iii) Its induction of chromosomal double-strand breaks in infected human cells and of mutagenesis in bacterial test systems. In addition, its unique regions that interact with DNA exhibit signs of diversifying selection. Our further analysis revealed similar oncogenic bacterium–restriction–enzyme pairs for other types of cancer. These results set another stage for cancer research and medicine around oncogenic restriction enzymes.
Year:
2025
BACKGROUND Ciprofloxacin resistant Klebsiella pneumoniae is common or emerging in many geographies, and knowledge of local resistance rates is important for empirical therapy. Whilst there are known K. pneumoniae ciprofloxacin resistance determinants, there is a lack of systematic data on the effect of determinants, alone and in combination, and there are no publicly accessible tools for predicting resistance from whole genome sequence data. METHODS The KlebNET-GSP AMR Genotype-Phenotype Group aggregated a matched genotype-phenotype dataset of n=12,167 K. pneumoniae species complex ( Kp SC) isolates from 27 countries between 2001-2021. We developed a rules-based classifier to predict ciprofloxacin resistance by categorizing the number of quinolone resistance determining regions mutations in gyrA and parC , the number of plasmid-mediated quinolone resistance genes, and the presence/absence of aac(6ʹ)-Ib-cr (which can acetylate ciprofloxacin). Predictive performance was assessed using the discovery dataset, for which we re-phenotyped discrepant isolates; and validated using externally contributed datasets (n=7,030 Kp SC isolates). RESULTS The rules-based classifier predicted R vs S/I with categorical agreement, sensitivity, and specificity >96%, and major/very major error rates <4%. Performance was similar across diverse Kp SC sources (human, animal, other), species, and intra-species lineages. External validation of the classifier yielded overall 93.12% categorical agreement [95% confidence interval (CI), 92.50-93.74%], 8.65% major errors [95% CI, 7.34-9.97%], and 6.20% very major errors [95% CI, 5.51-6.90%]. We implemented the classifier in Kleborate, a command-line tool that is integrated into the Pathogenwatch web platform. Using this to assess the global distribution of ciprofloxacin resistance determinants in Kp SC genomes available in Pathogenwatch (n=31,319, from 109 countries between years 2000-2023), we observed a significant positive association between national quinolone consumption rates and predicted ciprofloxacin resistance (R 2 =0.20, p=0.004). CONCLUSIONS Ciprofloxacin resistance phenotypes can be reasonably predicted from genotypes, which is sufficient for informing surveillance. However, unexplained resistance remains and accuracy is insufficient for clinical applications. We demonstrate the value of aggregating genotype-phenotype data to explore resistance mechanisms and develop predictors, but highlight complexities in combining phenotype data from different assays and standards.
Year:
2025
Osteomyelitis of the jaw is a severe inflammatory disorder that affects bones, and it is categorized into two main types: chronic bacterial and nonbacterial osteomyelitis. Although previous studies have investigated the association between these diseases and the oral microbiome, the specific taxa associated with each disease remain unknown. In this study, we conducted shotgun metagenome sequencing (≥10 Gb from ≥66,395,670 reads per sample) of bulk DNA extracted from saliva obtained from patients with chronic bacterial osteomyelitis (N = 5) and chronic nonbacterial osteomyelitis (N = 10). We then compared the taxonomic composition of the metagenome in terms of both taxonomic and sequence abundances with that of healthy controls (N = 5). Taxonomic profiling revealed a statistically significant increase in both the taxonomic and sequence abundance of Mogibacterium in cases of chronic bacterial osteomyelitis; however, such enrichment was not observed in chronic nonbacterial osteomyelitis. We also compared a previously reported core saliva microbiome (59 genera) with our data and found that out of the 74 genera detected in this study, 47 (including Mogibacterium ) were not included in the previous meta-analysis. Additionally, we analyzed a core-genome tree of Mogibacterium from chronic bacterial osteomyelitis and healthy control samples along with a reference complete genome and found that Mogibacterium from both groups was indistinguishable at the core-genome and pan-genome levels. Although limited by the small sample size, our study provides novel evidence of a significant increase in Mogibacterium abundance in the chronic bacterial osteomyelitis group. Moreover, our study presents a comparative analysis of the taxonomic and sequence abundances of all genera detected using deep salivary shotgun metagenome data. The distinct enrichment of Mogibacterium suggests its potential as a marker to distinguish between patients with chronic nonbacterial osteomyelitis and chronic bacterial osteomyelitis, particularly at the early stages when differences are unclear.
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Collaborators (65)
Paul Turner
University of Oxford
Ørjan Samuelsen
Professor
UiT The Arctic University of Norway
Helena Seth-Smith
Co-Leader of Microbial Genomics Devision
University of Zurich
Takahiro Niimura
Tokushima University Hospital
Nicole Stoesser
Associate Professor
University of Oxford
Amy Mathers
Professor
University of Virginia
Michael Bachman
Assistant Professor
University of Michigan
francesco pomilio
Head of Unit
Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche
Souichi Yanamoto
Professor
Hiroshima University
Sandra Reuter
Research Group Leader
University Medical Center Freiburg
Hitomi Kurosu
Senior researcher
National Institute of Infectious Diseases
Yukari Sato
Assistant professor
Tohoku University
Benjamin P. Howden
-
Arnfinn Sundsfjord
-
Alexandra Chiaverini
Ricercatore Sanitario (Cat. DS6) Veterinario
Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche
Sam Lipworth
University of Oxford
Motoi Suzuki
National Institute of Infectious Diseases
Andrew McArthur
Professor
McMaster University
Takeshi Terabayashi
准教授
Oita University
M. Estée Török
University of Cambridge
Charlene Rodrigues
Assistant Professor in Microbial Genomics
London School of Hygiene & Tropical Medicine
Adrian Egli
Professor
University of Zurich
Kathryn Holt
Professor (Research)
MONASH UNIVERSITY
Leah Wendy Roberts
Queensland University of Technology
Daniela Maria Cirillo
Head of Unit
Ospedale San Raffaele
Tommaso Giani
Associate Professor
University of Florence
Teresa M. Coque
-
Marianne Sunde
Norwegian Veterinary Institute
Gian Maria Rossolini
Professor
University of Florence
Jukka Corander
University of Oslo
Mónica Oleastro
PhD, Head of the National Reference Laboratory for Gastrointestinal Infections
Instituto Nacional de Saúde Doutor Ricardo Jorge
Mitsunori YOSHIDA
National Institute of Infectious Diseases
Motoyuki Sugai
-
Filipa Vale
Universidade de Lisboa Faculdade de Farmácia
Susana Campino
London School of Hygiene & Tropical Medicine
Iren H. Löhr
Stavanger University Hospital
D. Sassera
University of Pavia
Yusuke Minato
Associate Professor
Fujita Health University
Stephen Baker
University of Cambridge School of Clinical Medicine
Ichizo Kobayashi
基礎生物学研究所/National Institute for Basic Biology
Kelly L Wyres
MONASH UNIVERSITY
Katsuhiro Hanada
Oita University
Andrea Spitaleri
Researcher
Human Technopole
Norelle Sherry
Deputy Director
University of Melbourne
Eva Heinz
Senior Lecturer
University Of Strathclyde
Yumiko Hosaka
Senior Research Scientist
National Institute of Infectious Diseases
Naoki Osada
Associate Professor
Hokkaido University
Melese Hailu Legese
Lecturer
Uppsala Universitet Uppsala biomedicinska centrum
Hiroki Kitagawa
Hiroshima University Hospital
Marisa Haenni
-
Sylvain Brisse
Université Paris Cité
Edward Feil
Professor at Department of Life Sciences
University of Bath
Patrick N. A. Harris
University of Queensland
Taane Clark
Professor of Genomics and Global Health
London School of Hygiene & Tropical Medicine
Claire Gorrie
University of Melbourne
Masato Suzuki
National Institute of Infectious Diseases
Joao Perdigao
Professor do ensino Básico e Secundário
Ministério da Educação
Shizuo Kayama
National Institute of Infectious Diseases
Yoshihiko Hoshino
National Institute of Infectious Diseases
Satoshi Nakano
Visitting Researcher
Nagoya University
Hirokazu Yano
Senior Research Fellow
National Institute of Infectious Diseases
Nicholas Thomson
Head of Programme
Wellcome Sanger Institute
Harry Thorpe
University of Oslo
Nicholas Feasey
Professor
Liverpool School of Tropical Medicine
David Aanensen
Professor
University of Oxford
Make your next move.
Prepare your application
Review drafts before you send them.